NewsBenzingaEli Lilly riporta i risultati a 52 settimane che mostrano un’efficacia migliorata dallo studio clinico in aperto di fase 3b TOGETHER-Psa che valuta la combinazione Taltz-Zepbound nell’artrite psoriasica Eli Lilly riporta i risultati a 52 settimane che mostrano un’efficacia migliorata dallo studio clinico in aperto di fase 3b TOGETHER-Psa che valuta la combinazione Taltz-Zepbound nell’artrite psoriasica Benzinga 2026.11.11 14:49 (GMT+0) Open on Benzinga Other news US ADP employment change for week ending Oct. 31: 23,750, previous 19,750 Tether Capital Makes Strategic Investment in Stables to Expand USDT Cross-Border Payment Infrastructure in Asia and Middle East US SOL spot ETFs record single-day total net inflow of $11.684 million Is Wall Street Bullish or Bearish on Zimmer Biomet Stock? Clorox Stock Outlook: Is Wall Street Bullish or Bearish? Bitcoin spot ETFs see $7.99M total net inflow yesterday, led by BlackRock's IBIT with $76.5M
Tether Capital Makes Strategic Investment in Stables to Expand USDT Cross-Border Payment Infrastructure in Asia and Middle East